Users Discontinuing Slimming Jabs Regain Weight Far More Rapidly Compared to People Using Diet and Exercise

Image of medical injection and scale
Obesity treatment often requires long-term strategies.

Fresh analysis suggests that patients who come off blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds far faster than those who end traditional diet and exercise regimens.

Research printed in a leading medical journal shows that while overweight people frequently drop a large proportion of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals purchasing such treatments need to be cognizant of the risk of fast weight regain when the medication ends," warns expert Dr. Susan Jebb.

This pace of recovery means a return to starting mass within about 18 months.

Weighing Approaches

The study, which looked at dozens of studies involving thousands of patients, compared the outcomes of the injectable medications with older methods.

Researchers note that people who lose weight through dieting usually experience a more gradual creep back—around 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Doctors propose the way of the drugs explains the accelerated weight return.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Sustained high doses of GLP-1 concentrations several times higher than normal might result in the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement means hunger is uncontrolled, making binge eating much more probable."

A Lifelong Issue?

The NHS recommend the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

Many experts say that, due to the significant potential of relapse, the therapy might need to be ongoing.

This perspective is reinforced by drug manufacturers, who say that the findings "emphasize the persistent character of obesity," similar to managing conditions like diabetes.

Patient Testimonies

People who have stopped the jabs report a sudden return of appetite.

"It felt as if something that goes on and I was suddenly extremely hungry," recalled one woman.

This challenge is worsened if individuals have not established sustainable lifestyle or habit changes during treatment.

Widespread Use

Figures show that a significant number of people in the UK have tried these injections in the last 12 months, with desire remaining high.

  • Use is greater among women compared to males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, clinicians emphasize that while the jabs are effective tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on combined lifestyle changes.

Joseph Griffin
Joseph Griffin

Elara Vance is a travel writer and UK expat based in Las Vegas, sharing insights on local culture and expat experiences.